Copyright Reports & Markets. All rights reserved.

Global Nuclear Medicine Equipment Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Nuclear Medicine Equipment Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Nuclear Medicine Equipment Market Size Growth Rate by Product
      • 1.4.2 SPECT
      • 1.4.3 Hybrid SPECT
      • 1.4.4 Standalone SPECT
      • 1.4.5 Hybrid PET
    • 1.5 Market by End User
      • 1.5.1 Global Nuclear Medicine Equipment Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Imaging Centers
      • 1.5.4 Academic & Research Institutes
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Nuclear Medicine Equipment Market Size
      • 2.1.1 Global Nuclear Medicine Equipment Revenue 2014-2025
      • 2.1.2 Global Nuclear Medicine Equipment Sales 2014-2025
    • 2.2 Nuclear Medicine Equipment Growth Rate by Regions
      • 2.2.1 Global Nuclear Medicine Equipment Sales by Regions
      • 2.2.2 Global Nuclear Medicine Equipment Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Nuclear Medicine Equipment Sales by Manufacturers
      • 3.1.1 Nuclear Medicine Equipment Sales by Manufacturers
      • 3.1.2 Nuclear Medicine Equipment Sales Market Share by Manufacturers
      • 3.1.3 Global Nuclear Medicine Equipment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Nuclear Medicine Equipment Revenue by Manufacturers
      • 3.2.1 Nuclear Medicine Equipment Revenue by Manufacturers (2014-2019)
      • 3.2.2 Nuclear Medicine Equipment Revenue Share by Manufacturers (2014-2019)
    • 3.3 Nuclear Medicine Equipment Price by Manufacturers
    • 3.4 Nuclear Medicine Equipment Manufacturing Base Distribution, Product Types
      • 3.4.1 Nuclear Medicine Equipment Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Nuclear Medicine Equipment Product Type
      • 3.4.3 Date of International Manufacturers Enter into Nuclear Medicine Equipment Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Nuclear Medicine Equipment Sales by Product
    • 4.2 Global Nuclear Medicine Equipment Revenue by Product
    • 4.3 Nuclear Medicine Equipment Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Nuclear Medicine Equipment Breakdown Data by End User

    6 North America

    • 6.1 North America Nuclear Medicine Equipment by Countries
      • 6.1.1 North America Nuclear Medicine Equipment Sales by Countries
      • 6.1.2 North America Nuclear Medicine Equipment Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Nuclear Medicine Equipment by Product
    • 6.3 North America Nuclear Medicine Equipment by End User

    7 Europe

    • 7.1 Europe Nuclear Medicine Equipment by Countries
      • 7.1.1 Europe Nuclear Medicine Equipment Sales by Countries
      • 7.1.2 Europe Nuclear Medicine Equipment Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Nuclear Medicine Equipment by Product
    • 7.3 Europe Nuclear Medicine Equipment by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Nuclear Medicine Equipment by Countries
      • 8.1.1 Asia Pacific Nuclear Medicine Equipment Sales by Countries
      • 8.1.2 Asia Pacific Nuclear Medicine Equipment Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Nuclear Medicine Equipment by Product
    • 8.3 Asia Pacific Nuclear Medicine Equipment by End User

    9 Central & South America

    • 9.1 Central & South America Nuclear Medicine Equipment by Countries
      • 9.1.1 Central & South America Nuclear Medicine Equipment Sales by Countries
      • 9.1.2 Central & South America Nuclear Medicine Equipment Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Nuclear Medicine Equipment by Product
    • 9.3 Central & South America Nuclear Medicine Equipment by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Nuclear Medicine Equipment by Countries
      • 10.1.1 Middle East and Africa Nuclear Medicine Equipment Sales by Countries
      • 10.1.2 Middle East and Africa Nuclear Medicine Equipment Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Nuclear Medicine Equipment by Product
    • 10.3 Middle East and Africa Nuclear Medicine Equipment by End User

    11 Company Profiles

    • 11.1 Philips
      • 11.1.1 Philips Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Philips Nuclear Medicine Equipment Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Philips Nuclear Medicine Equipment Products Offered
      • 11.1.5 Philips Recent Development
    • 11.2 Siemens
      • 11.2.1 Siemens Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Siemens Nuclear Medicine Equipment Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Siemens Nuclear Medicine Equipment Products Offered
      • 11.2.5 Siemens Recent Development
    • 11.3 Digirad
      • 11.3.1 Digirad Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Digirad Nuclear Medicine Equipment Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Digirad Nuclear Medicine Equipment Products Offered
      • 11.3.5 Digirad Recent Development
    • 11.4 Mediso Medical Imaging Systems
      • 11.4.1 Mediso Medical Imaging Systems Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Mediso Medical Imaging Systems Nuclear Medicine Equipment Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Mediso Medical Imaging Systems Nuclear Medicine Equipment Products Offered
      • 11.4.5 Mediso Medical Imaging Systems Recent Development
    • 11.5 Toshiba
      • 11.5.1 Toshiba Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Toshiba Nuclear Medicine Equipment Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Toshiba Nuclear Medicine Equipment Products Offered
      • 11.5.5 Toshiba Recent Development
    • 11.6 Bozlu
      • 11.6.1 Bozlu Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Bozlu Nuclear Medicine Equipment Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Bozlu Nuclear Medicine Equipment Products Offered
      • 11.6.5 Bozlu Recent Development
    • 11.7 Neusoft
      • 11.7.1 Neusoft Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Neusoft Nuclear Medicine Equipment Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Neusoft Nuclear Medicine Equipment Products Offered
      • 11.7.5 Neusoft Recent Development
    • 11.8 Compañía Mexicana
      • 11.8.1 Compañía Mexicana Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Compañía Mexicana Nuclear Medicine Equipment Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Compañía Mexicana Nuclear Medicine Equipment Products Offered
      • 11.8.5 Compañía Mexicana Recent Development
    • 11.9 SurgicEye
      • 11.9.1 SurgicEye Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 SurgicEye Nuclear Medicine Equipment Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 SurgicEye Nuclear Medicine Equipment Products Offered
      • 11.9.5 SurgicEye Recent Development
    • 11.10 CMR Naviscan
      • 11.10.1 CMR Naviscan Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 CMR Naviscan Nuclear Medicine Equipment Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 CMR Naviscan Nuclear Medicine Equipment Products Offered
      • 11.10.5 CMR Naviscan Recent Development
    • 11.11 DDD-Diagnostic
    • 11.12 Positron
    • 11.13 TeraRecon
    • 11.14 GE Healthcare
    • 11.15 CMR Naviscan

    12 Future Forecast

    • 12.1 Nuclear Medicine Equipment Market Forecast by Regions
      • 12.1.1 Global Nuclear Medicine Equipment Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Nuclear Medicine Equipment Revenue Forecast by Regions 2019-2025
    • 12.2 Nuclear Medicine Equipment Market Forecast by Product
      • 12.2.1 Global Nuclear Medicine Equipment Sales Forecast by Product 2019-2025
      • 12.2.2 Global Nuclear Medicine Equipment Revenue Forecast by Product 2019-2025
    • 12.3 Nuclear Medicine Equipment Market Forecast by End User
    • 12.4 North America Nuclear Medicine Equipment Forecast
    • 12.5 Europe Nuclear Medicine Equipment Forecast
    • 12.6 Asia Pacific Nuclear Medicine Equipment Forecast
    • 12.7 Central & South America Nuclear Medicine Equipment Forecast
    • 12.8 Middle East and Africa Nuclear Medicine Equipment Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Nuclear Medicine Equipment Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Nuclear medicine utilizes radionuclides, which are unstable atoms that emit radiation spontaneously, to examine and treat diseases such as, cancer, cardiovascular, and others.
      The market growth is driven by the emergence of latest and advanced products, development in clinics and centers for diagnostic imaging, advancement in radiotracers, and increase in number of patients with cancer and cardiac ailments.
      Asia-Pacific and LAMEA possess high market potential, owing to rise in prevalence of cancer and other chronic diseases, rising awareness about the early diagnosis of cancer, growth in demand for nuclear medicine equipment, and presence of untapped opportunities.
      The nuclear medicine equipment market share in Argentina is projected to grow at a CAGR of 6.0% during the forecast period, as Argentina has the highest number of breast and colon cancer cases worldwide, which is expected to drive the market growth.
      The global Nuclear Medicine Equipment market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Nuclear Medicine Equipment market based on company, product type, end user and key regions.

      This report studies the global market size of Nuclear Medicine Equipment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Nuclear Medicine Equipment in these regions.
      This research report categorizes the global Nuclear Medicine Equipment market by top players/brands, region, type and end user. This report also studies the global Nuclear Medicine Equipment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Philips
      Siemens
      Digirad
      Mediso Medical Imaging Systems
      Toshiba
      Bozlu
      Neusoft
      Compañía Mexicana
      SurgicEye
      CMR Naviscan
      DDD-Diagnostic
      Positron
      TeraRecon
      GE Healthcare
      CMR Naviscan

      Market size by Product
      SPECT
      Hybrid SPECT
      Standalone SPECT
      Hybrid PET
      Market size by End User
      Hospitals
      Imaging Centers
      Academic & Research Institutes

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Nuclear Medicine Equipment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Nuclear Medicine Equipment market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Nuclear Medicine Equipment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Nuclear Medicine Equipment submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Nuclear Medicine Equipment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Nuclear Medicine Equipment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now